Compartir
CFR 21, Parts 1 to 99, Food and Drugs, April 01, 2016 (Volume 1 of 9) (en Inglés)
Office of the Federal Register (Cfr)
(Autor)
·
Regulations Press
· Tapa Blanda
CFR 21, Parts 1 to 99, Food and Drugs, April 01, 2016 (Volume 1 of 9) (en Inglés) - Office of the Federal Register (Cfr)
$ 101.65
$ 156.38
Ahorras: $ 54.73
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Estados Unidos
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Lunes 15 de Julio y el
Miércoles 24 de Julio.
Lo recibirás en cualquier lugar de Ecuador entre 1 y 3 días hábiles luego del envío.
Reseña del libro "CFR 21, Parts 1 to 99, Food and Drugs, April 01, 2016 (Volume 1 of 9) (en Inglés)"
Code of Federal Regulations Title 21, Volume 1, April 1, 2016 contains regulations governing Food and Drugs and may also be referenced as: - Code of Federal Regulations Title 21, Volume 1, April 1, 2016- CFR Title 21- CFR 21, Food and Drugs- CFR 21, Parts 1 to 99, Food and DrugsThis volume contains Parts 1 to 99: - Part 1; GENERAL ENFORCEMENT REGULATIONS- Part 2; GENERAL ADMINISTRATIVE RULINGS AND DECISIONS- Part 3; PRODUCT JURISDICTION- Part 4; REGULATION OF COMBINATION PRODUCTS- Part 5; ORGANIZATION- Part 7; ENFORCEMENT POLICY- Part 10; ADMINISTRATIVE PRACTICES AND PROCEDURES- Part 11; ELECTRONIC RECORDS; ELECTRONIC SIGNATURES- Part 12; FORMAL EVIDENTIARY PUBLIC HEARING- Part 13; PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRY- Part 14; PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE- Part 15; PUBLIC HEARING BEFORE THE COMMISSIONER- Part 16; REGULATORY HEARING BEFORE THE FOOD AND DRUG ADMINISTRATION- Part 17; CIVIL MONEY PENALTIES HEARINGS- Part 19; STANDARDS OF CONDUCT AND CONFLICTS OF INTEREST- Part 20; PUBLIC INFORMATION- Part 21; PROTECTION OF PRIVACY- Part 25; ENVIRONMENTAL IMPACT CONSIDERATIONS- Part 26; MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN COMMUNITY- Part 50; PROTECTION OF HUMAN SUBJECTS- Part 54; FINANCIAL DISCLOSURE BY CLINICAL INVESTIGATORS- Part 56; INSTITUTIONAL REVIEW BOARDS- Part 58; GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES- Part 60; PATENT TERM RESTORATION- Part 70; COLOR ADDITIVES- Part 71; COLOR ADDITIVE PETITIONS- Part 73; LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION- Part 74; LISTING OF COLOR ADDITIVES SUBJECT TO CERTIFICATION- Part 80; COLOR ADDITIVE CERTIFICATION- Part 81; GENERAL SPECIFICATIONS AND GENERAL RESTRICTIONS FOR PROVISIONAL COLOR ADDITIVES FOR USE IN FOODS, DRUGS, AND COSMETICS- Part 82; LISTING OF CERTIFIED PROVISIONALLY LISTED COLORS AND SPECIFICATIONS- Parts 83-98; Reserved- Part 99; DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES